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PI3KCocaine is an addictive substance with a potential to cause deleterious effects in the brain. The strategies for
treating its neurotoxicity, however, are limited. Evidence suggests that the endocannabinoid system exerts
neuroprotective functions against various stimuli. Thus, we hypothesized that inhibition of fatty acid amide hy-
drolase (FAAH), the main enzyme responsible for terminating the actions of the endocannabinoid anandamide,
reduces seizures and cell death in the hippocampus in a model of cocaine intoxication. Male Swiss mice received
injections of endocannabinoid-related compounds followed by the lowest dose of cocaine that induces seizures,
electroencephalographic activity and cell death in the hippocampus. Themolecular mechanismswere studied in
primary cell culture of this structure. The FAAH inhibitor, URB597, reduced cocaine-induced seizures and epilep-
tiform electroencephalographic activity. The cannabinoid CB1 receptor selective agonist, ACEA, mimicked these
effects, whereas the antagonist, AM251, prevented them. URB597 also inhibited cocaine-induced activation
and death of hippocampal neurons, both in animals and in primary cell culture. Finally, we investigated if the
PI3K/Akt/ERK intracellular pathway, a cell surviving mechanism coupled to CB1 receptor, mediated these neuro-
protective effects. Accordingly, URB597 injection increased ERK and Akt phosphorylation in the hippocampus.
Moreover, the neuroprotective effect of this compound was reversed by the PI3K inhibitor, LY294002. In conclu-
sion, the pharmacological facilitation of the anandamide/CB1/PI3K signaling protects the brain against cocaine in-
toxication in experimental models. This strategy may be further explored in the development of treatments for
drug-induced neurotoxicity.
© 2015 Elsevier Inc. All rights reserved.Introduction
Addiction is a major public health problem with a high prevalence
worldwide. Among the most commonly addictive drugs is cocaine, a
psychostimulant and psychotomimetic compound (Degenhardt and
Hall, 2012), which may induce acute and chronic psychiatric andpe-1receptor;CB2,cannabinoid
Δ9-tetrahydrocannabinol; EEG,
lated kinase; FAAH, fatty acid
1, transient receptor potential
ences, Universidade Federal de
orizonte, MG, Brazil. Fax: +55
, fabriciomoreira@icb.ufmg.brneurological effects, including psychosis, agitation and seizures (Cadet
et al., 2014). Themolecular targets underlying cocaine-induced psycho-
sis and behavioral stimulation include inhibition of neuronal mono-
amine uptake, particularly dopamine (Wise, 1984; Koob and Nestler,
1997). Accordingly, these effects are reversed by antipsychotic drugs,
mainly through antagonism at dopamine D2 receptor (Kishi et al.,
2013). The mechanisms underlying the neurotoxic effects of this drug
are less understood, since several intracellular biochemical processes
seem to be involved (Cunha-Oliveira et al., 2008; Planeta et al., 2013).
Thus, experimentalmodels of cocaine intoxication are relevant for study-
ing its biological mechanisms as well as new treatment approaches
(Connors and Hoffman, 2013; Heard et al., 2011).
One possible strategy to reduce cocaine-induced neural damage
would be facilitating protective mechanisms already at play in the
brain. In this context, the endocannabinoid system has been proposed
as an on-demand defense mechanism against neural hyper-excitability
(Lutz, 2004; van der Stelt and Di Marzo, 2005; Fowler et al., 2010). This
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stituent isΔ9-tetrahydrocannabinol (Δ9-THC). The typical components of
the endocannabinoid system are the cannabinoid CB1 and CB2 receptors,
their endogenous agonists (endocannabinoids), among which are
arachidonoyl ethanolamide (anandamide) and 2-arachidonoyl glycerol;
and the mechanisms mediating their synthesis and hydrolysis (Piomelli,
2003). The primary enzyme responsible for terminating anandamide ac-
tions is fatty acid amide hydrolase (FAAH) (Cravatt et al., 1996). Speciﬁc
compounds have been developed to inhibit this enzyme and facilitate
endocannabinoid signaling (Kathuria et al., 2003).
Cannabinoids and the endocannabinoid system have been investigat-
edmainly in relation to their effects upon cocaine self-administration and
psychomotor stimulation (Panlilio et al., 2010; Xi and Gardner, 2008;
Moreira et al., 2015). Anandamide, however, is synthesized and release
particularly in response to excessive neural activity, providing on-
demand protection though CB1 receptor signaling in the hippocampus
(Marsicano et al., 2003; Monory et al., 2006). Moreover, compounds
that inhibit anandamide hydrolysis induce neuroprotective effects
(Karanian et al., 2007; Slusar et al., 2013) and attenuate seizures and elec-
troencephalographic (EEG) activity induced by experimental convulsant
substances (Karanian et al., 2007; Vilela et al., 2013, 2014). Thus, it is
reasonable to suppose that CB1 receptor activation also protects against
cocaine toxicity. Indeed, one study observed that cannabinoids reduce
seizures induced by various substances, including cocaine (Hayase
et al., 2001). In spite of this evidence, the effects of anandamide hydro-
lysis inhibition upon cocaine neurotoxicity have not been investigated.
Importantly, compounds acting through this mechanism facilitate the
on-demand actions of anandamide and therefore have low propensity
to induce motor impairment and other deleterious outcomes. This is
in contrast to Δ9-THC and other cannabinoids, which directly activate
the CB1 receptor and lack spatial and temporal resolution in their
actions (Moreira and Wotjak, 2010).
The CB1 receptor is coupled to diverse intracellular signaling
pathways, including the phosphoinositide 3-kinase/protein kinase B/
extracellular signal-regulated kinase (PI3K/Akt/ERK) pathway, which
is known to exert neuroprotective functions (Galve-Roperh et al.,
2002; Ozaita et al., 2007). Considering these pieces of evidence, we hy-
pothesized that facilitating anandamide actions confers protection
against cocaine excitotoxic through recruitment of the intracellular
PI3K/Akt/ERK pathway in the hippocampus. Thus, we tested the effects
of FAAH inhibition against seizures, EEG activity and hippocampal cell
death in an experimental model of acute cocaine intoxication. To inves-
tigate the role of theCB1 receptor/PI3K/Akt/ERk pathway,we performed
experiments with selective compounds both in animals and in hippo-
campal cell culture.
Methods
Animals. Male Swiss mice (20–30 g) from the animal facility of the
Federal University of Minas Gerais were kept on a 12 h:12 h dark/light
cycle at 22 ± 1 °C with free access to food and water. All efforts were
made to minimize animal suffering and to employ the least number of
animals in each experiment. The protocols are in accordance with
the Ethical Committee for Animal Experimentation (CETEA) of this
University (Protocol 242/2013), which follows the Brazilian law no.
11.794/2008 and are in accordance with the international statement
on the requirement for research involving animals (The Basel Declara-
tion) and the Concordat on Openness on Animal Research.
Chemicals and injection protocols. The following compounds were
used: The selective FAAH-inhibitor, [3-(3-carbamoylphenyl)phenyl]N-
cyclohexylcarbamate (URB597); the CB1 receptor selective agonist
arachidonoyl chloroethylamide (ACEA); the CB1 receptor antagonist/
inverse agonist, 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-meth-
yl-N-1-piperidinyl-1H-pyrazole-3 carboxamide (AM251). They were
purchased from Cayman Chemical Company (1180 East EllsworthRoad, Ann Arbor, Michigan 48108, USA) and suspended in ethanol/
cremophor (Sigma)/0.9% saline (1:1:18). Cocaine hydrochloride
(Merck, Whitehouse Station, New Jersey, USA) was dissolved in saline;
and the PI3K inhibitor 2-morpholin-4-yl-8-phenylchromen-4-one
(LY294002; Tocris, Tocris House, IO Centre, Moorend Farm Ave, Bristol,
Avon BS11 0QL, UK), was dissolved in DMSO 1% with a ﬁnal concentra-
tion of 0.1%. All compounds have purity higher than 98%, as informed by
each supplier. Rabbit anti-phospho Akt, anti-phospho ERK1/2, anti-Akt
and anti-ERK1/2 monospeciﬁc clonal antibodies were from DB Biotech
(Kosice, Slovakia). All injections were performed intraperitoneally
(i.p.) in a volume of 1 ml kg−1.
Surgery. The animals were anesthetized with ketamine (60 mg kg−1)
and xylazine (8 mg kg−1) and positioned in a stereotaxic frame
(DavidKopfmodel 960). Stainless steel bone-screwelectrodes (Fine Sci-
ences Tools, mod. 19010-00) were placed over parietal cortices and ﬁxed
to the skull with zinc cement and soldered to pin bars. Coordinates (AP=
2.0 mm, ML =± 2.0 mm referenced from the bregma suture) were de-
rived from a stereotaxic atlas for mice (Paxinos andWatson, 1997). A ref-
erence electrode was inserted into the nasal bone. The animals received
prophylactic intramuscular injections of polyantibiotic (0.27 g kg−1;
benzylpenicillin, streptomycin and dihydrostreptomycin Pentabiotico®,
Fort Dodge, Brazil) and the nonsteroidal anti-inﬂammatory drug
ﬂunixinmeglumine (0.025 g kg−1; Banamine®, Schering Plough, Brazil).
They were allowed to recover for 4–5 days before the experiments.
Cocaine-induced seizures. For quantiﬁcation of seizures, the animals re-
ceived cocaine injections and were immediately placed in individual
chambers for 10 min in an isolated room. The lowest seizure-inducing
dose of cocaine was selected based on a dose–response curve. Seizure
was deﬁned as the occurrence of tail clonus with myoclonic jerks and
wild jumping or convulsions with loss of righting reﬂex (Gasior et al.,
1999; Vilela et al., 2013). An experimenter, unaware of the treatments,
quantiﬁed the latency and duration of seizures. Vehicle or URB597
were administered 30 min before cocaine. The CB1 receptor antagonist
AM251 was administered 10 min before URB597.
Electroencephalograﬁc recording and analysis. Video-EEG recordings
were performed starting 1 min before cocaine administration until
30 s after the seizures onset. The EEG signal was ampliﬁed (5000×), ﬁl-
tered (1 Hz high pass and 500 Hz low pass) and digitized using an A/D
converter set at a sampling rate of 1 kHz (Aisha4 Kananda® Ltda, Belo
Horizonte, MG, Brazil); the data were stored in a personal computer.
The records were analyzed off-line according to the latency to the
onset and the duration of the epileptiformdischarge (Vilela et al., 2013).
Fos immunohistochemistry. Two hours after cocaine administration, an-
imals were anesthetized with an overdose of urethane and perfused
transcardially with saline (200 nl) followed by 4% paraformaldehyde
(PFA 4%) in 0.1 M phosphate buffer (150 ml, pH 7.4). Brains were
removed and post ﬁxed over 2 h in PFA 4% and stored for 36 h in 30%
sucrose for cryoprotection. Coronal sections (40 μm) were obtained in
a cryostat in triplicate for imunohystochemistry, as previously described
(Beijamini and Guimarães, 2006). Brieﬂy, tissue sections were washed
with phosphate buffer in saline (PBS) and incubated overnight at
room temperature with rabbit IgG in PBS (1:1000). The sections were
washed in PBS and incubated with a biotinilated anti-rabbit IgG
(1:1000). Fos immunoreactivity was revealed by the addition of the
chromogen diaminobenzidin (DAB, from Sigma) and visualized as a
brown precipitate inside the neuronal nuclei.
Cell death in the hippocampal tissue from cocaine-treated animals. The
animals were killed by cervical displacement 24 h after cocaine injec-
tions. Their brains were rapidly (b1 min) removed and submerged in
cold (2–3 °C) ACSF (artiﬁcial cerebrospinal ﬂuid) solution: (in mM)
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cose bubbled with 95% O2, 5% CO2, PH 7.4. In addition, the brain was
placed in inside the vibratome (Vibratome, Series 1000, Technical Prod-
ucts International) andwas cut in transverse slices (400 μm) containing
the hippocampal formation (Leite et al., 2012). For the analysis of cell vi-
ability, the sliceswere incubatedwith 6mMethidiumhomodimer (live/
dead assay, Molecular Probes, Inc.) for 30 min, then washed for 15 min
in 2 ml of 95% O2/5% CO2 ACSF at room temperature. After, the slices
were ﬁxed in paraformaldehyde 4% for 15 min, washed for 5 min in
PBS and again washed in ACSF. During the staining procedure the slices
were protected from light. Dead cells were indicated by the red ﬂuores-
cence of ethidium homodimer. Images were acquired using a ﬂuores-
cence microscope Axio Imager.M2 - Zeiss system using 10× objective.
Fluorescence images showing speciﬁc red-ﬂuorescent nucleic acid
staining of dead cells were collected. We used the Carl Zeiss Axiovision
4.8 software to acquire and create images reconstructions. To improve
images for quantitative analysis, they were processed using themedian
ﬁlter. In the current approach, we deﬁne nucleus as connected pixels
that were above a threshold. This threshold was calculated using the
image histogram, and the pixels below the threshold were set to 0.
Slices containing CA1 and DG region of the hippocampus were selected
and analyzed using the Image J software to calculate the percentage of
threshold area in the image which, indirectly, reﬂects the number of
dead cells.
Immunoblotting for Akt and ERK1/2. To investigate drug effects upon Akt
and ERK1/2 phosphorylation, the hippocampi were dissected and lysed
in Triton buffer (1% Triton X-100, 0.15M NaCl, 0.05M Tris–HCl, pH 7.2)
containing protease inhibitors (1.0 mM AEBSF and 10.0 μg/ml of
both leupeptin and aprotinin). An amount of 100.0 μg of total cellular
protein for each sample was subjected to SDS-PAGE, followed by
electroblotting onto nitrocellulose membranes. Membranes were
blocked with 5% BSA in wash buffer (150.0 mM NaCl, 10.0 mM Tris–
HCl, pH 7.0 and 0.05% Tween 20) for 1 h and then incubated with either
rabbit anti-phosphoAkt (S473) or anti-phospho ERK1/2 (Thr202/
Thr204) (1:1000) antibodies in wash buffer containing 3% BSA for 2 h
at room temperature. Membranes were rinsed three times with wash
buffer and then incubated with secondary HRP-conjugated goat anti-
rabbit IgG diluted 1:5000 in wash buffer containing 3% skim milk for
1 h. Later, they were incubated with ECLWestern blotting detection re-
agents. Antibodies were then stripped and membranes were incubated
with either anti-Akt or anti-ERK1/2 (1:1000) for 2 h and probed with
secondary antibody to determine total Akt and ERK1/2 expression.
Nonsaturated, immunoreactive Akt and ERK1/2 bands were quantiﬁed
by scanning densitometry. Immuno-band intensity was calculated
using ImageJ TM software. The number of pixels of Akt phospho-
bands and ERK1/2phospho-bandswere dividedby thenumber of pixels
of total Akt and ERK1/2, respectively, to normalize the levels of phos-
phorylated kinases to total kinase expression (Doria et al., 2013;
Ribeiro et al., 2010). The treatment groups were compared to the
basal levels (vehicle groups) of phosphorylation, which is presented as
100% values.
Cell death in primary culture of the hippocampus. Neuronal cultures were
prepared from the hippocampus region of C57 mouse embryo brains at
the embryonary day19. The purity of the cell culturewas determined by
NeuN staining, whichwas expressed in 95% of the cell as being classiﬁed
as neurons (Doria et al., 2013). After dissection, the tissue was submit-
ted to trypsin digestion followed by cell dissociation using a ﬁre-
polished Pasteur pipette. Cells were plated on poly-L-ornithine-coated
dishes in neurobasal medium supplemented with N2 and B27 supple-
ments, 2.0 mMGlutaMAX, 50.0 mg/ml penicillin and 50.0 mg/ml strep-
tomycin. Cells were incubated at 37 °C and 5% CO2 in a humidiﬁed
incubator and cultured for 10–12 days in vitrowith medium replenish-
ment every 4 days.For the cell death assay, the plates were incubated for 20 h with ei-
ther vehicle or cocaine (from a 25 μM to 1000 μM) combined with
URB597, AM251 and LY294002. Cell death was determined by a live/
dead viability assay, as described previously (Ribeiro et al., 2010). Brief-
ly, neurons were stainedwith 2.0mMcalceinacetoxymethyl ester (AM)
and 2.0 mM ethidium homodimer-1 for 15min and the fractions of live
(calcein AM positive) and dead (ethidium homodimer-1 positive) cells
were determined. The cells were visualized by ﬂuorescencemicroscopy
EVOS® FLOID® Cell Imaging Station (Life Technologies, Carlsbad, CA,
USA) and scored by a blinded observer. A minimum of 300 cells were
analyzed per well in triplicate using ImageJ software. Dead cells were
expressed as a percentage of the total number of cells (Doria et al.,
2013).
Data analysis. The dependent variables were subjected to one- or
two-way ANOVA, as appropriate, followed by Newman–Keuls post
hoc test. Data are presented as mean ± SEM. The signiﬁcance level
was considered at p b 0.05. The statistical software used was the
GraphPad Prism 5.0 Version for Windows (San Diego, CA, USA).
Results
URB597, an anandamide hydrolysis inhibitor, reduces cocaine-induced
seizures in mice
Theﬁrst experiment consisted of a dose–response curve for selecting
the lowest dose of cocaine able to induce seizures in mice. Administra-
tion of cocaine at doses of 75 and 100 mg kg−1 induced seizures, as re-
vealed by their latency (F3,20 = 81.99, p b 0.0001; Fig. 1A) and duration
(F3,24 = 14.81, p b 0.0001; Fig. 1B). Next, we investigated whether
URB597 (0.3, 1.0 and 3.0 mg kg−1) could reduce cocaine-induced sei-
zures. This substance was effective, at the dose of 1.0 mg kg−1, in both
increasing seizure latency (F3,28= 5.779, p= 0.003; Fig. 1C) and reduc-
ing seizure duration (F3,28 = 3.853, p = 0.02; Fig. 1D). This effect was
conﬁrmed in an independent experiment by treating animals with the
CB1 receptor selective agonist, ACEA (1, 2 and 4 mg kg−1), which
increased seizure latency at the intermediate dose (F3,27 = 3.761, p =
0.02; Fig. 1E), although the effects upon seizure duration did not reach
signiﬁcance (F3,27 = 1.245, ns; Fig. 1F).
The protective effects of URB597 against cocaine-induced seizures and
electroencephalograﬁc activity are mediated by the CB1 receptor
We tested the hypothesis that the effects of URB597 would be
prevented by a CB1 receptor antagonist. As in the previous experiment,
URB597 inhibited the effects of cocaine, increasing seizure latency and
decreasing duration. AM251, at the dose of 1.0 mg kg−1 reversed the
anticonvulsant effect of URB597 for both latency (F3,27 = 8.325, p =
0.001; Fig. 2A) and duration (F3,27 = 3.359, p = 0.04; Fig. 2B) of sei-
zures. These behavioral results were paralleled by the effects of these
drugs upon EEG recordings. AM251 reversed the effects of URB597
upon cocaine-induced EEG activity latency (F3,20 = 8.538,p = 0.002;
Fig. 2C) and duration (F3,21 = 5.718, p = 0.01; Fig. 2D). This dose
of AM251 was ineffective by itself (data not shown). Representative
recordings of EEG activity after each treatment are presented in Fig. 3.
URB597 inhibits cocaine-induced c-Fos protein expression the hippocampus
We hypothesized that the CA1 region and dentate gyrus of the hip-
pocampus are related to cocaine-induced seizures, considering the
role of these regions in elaborating ictal activity. Indeed, immunostain-
ingwith c-Fos antibody indicated a signiﬁcant increase in the number of
Fos-positive cells in the CA1 region of hippocampus in cocaine-treated
animals, which was abolished by URB597. There was no overall effect
of URB597 (F1,15 = 0.923, ns); a signiﬁcant cocaine effect (F1,15 =
9.101, p = 0.0087) and a interaction between factor (F1,15 = 7.802;
Fig. 1. Effects of cocaine and pre-treatments with URB597 and ACEA on seizures in mice. (A, B) Cocaine induced seizure as quantiﬁed by their latency and duration in comparison to
vehicle-treated animals. (C, D) The anandamide hydrolysis inhibitor, URB597, inhibited cocaine-induced seizures. (E, F) The CB1 receptor selective agonist, ACEA, also attenuated
cocaine-induced seizures. *p b 0.05, **p b 0.01 and ***p b 0.001 compared to the respective vehicle (Veh) groups; one-way ANOVA followed by Newman–Keuls test. Data are expressed
as mean ± SEM (n = 6–9, n = 8–11 and n = 7–8 per group).
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expression and URB597 selective prevented this effect (Fig. 4A). No
alteration, however, was found in the dentate gyrus. Therewas no effect
of URB597 treatment (F1,15=0.5116, ns) or cocaine (F1,15=0.1161, ns)
and no interaction between factors (F1,15 = 0.4645, ns), as shown in
Fig. 4B. Altogether, these results suggest that reductions in cocaine-
induced neuronal activation in CA1 region of hippocampus mayFig. 2. Role of CB1 receptor in the protective effects of URB597 against cocaine-induced seizure
reversed the protective effects of URB597 on cocaine-induced seizures. (C, D) These effe
vehicle + vehicle (Veh) group; #p b 0.05 and ##p b 0.01 compared to Veh + URB597 group;
(n = 10 mice/group).contribute for the anticonvulsant effect of URB597. Representative pho-
tomicrographies of Fos- positive cells can be seen in Fig. 4C–F.
URB597 inhibits cocaine-induced cell death in the hippocampus
In the next set of experiments, we sought to determine whether a
pre-treatment with URB597 would also protect against cell death ins and EEG activity in mice. (A, B) Pre-treatment with the CB1 receptor antagonist, AM251,
cts were paralleled by effects on EEG-activity. *p b 0.05 and **p b 0.01 compared to
one-way ANOVA followed by Newman–Keuls test. Data are expressed as mean ± SEM
Fig. 3.Representative EEG recordings for AM251 (1mg/kg), URB597 (1mg/kg) and cocaine (75mg/kg) treatedmice. Vertical bars show the beginning of recording and the beginning and
end of seizures activity.
182 L.R. Vilela et al. / Toxicology and Applied Pharmacology 286 (2015) 178–187the hippocampus of cocaine-treated animals. There was an increase
of cell death in CA1 region and dentate gyrus of hippocampus
deﬁned by higher ﬂuorescence of these areas. URB597 signiﬁcantly
attenuated overall hippocampal cell death in CA1 region. There was
no effect of URB597 factor (F1.18 = 0.3645, ns); as expected, there
was an overall effect of cocaine in increasing cell death (F1.18 =
11.13; 0.0037); and there was an interaction between factors
(F1.18 = 3.608; 0.0474), with post-hoc analysis showing thatFig. 4. Effects of the anandamide hydrolysis inhibitor, URB597 (1 mg kg−1), on cocaine (75
hippocampus 2 h after the convulsive seizures. (A) URB597 reduced cocaine-induced cFos expr
photomicrographies of cFos-positive cells in the hippocampus (coronal sections, 40 μm) for eac
hicle-vehicle (Veh) group; ##p b 0.01 compared to Veh + cocaine group; one-way ANOVA follURB597 prevented cocaine-induced cell death (Fig. 5A). A similar
proﬁle has been observed in the dentate gyrus. There was no overall
effect of URB597 (F1.18 = 2.922, ns), there was a cocaine effect
(F1.18 = 5.972, p = 0.0291) and an interaction between factors
(F1.18 = 8.065, p = 0.0109), again with post-hoc analysis indicating
that URB597 also protected against cell death in this part of the hip-
pocampus (Fig. 5B). Representative images of ethidum bromide
staining for each group are depicted in Fig. 5C–J.mg kg−1)-induced cFos expression in the CA1 and dentate gyrus regions of the mouse
ession in the CA1. (B) No changewas observed in the dentate gyrus. (C–F) Representative
h experimental group. Bar size: 100 μm.Magniﬁcation= 20×. **p b 0.01 compared to ve-
owed by Newman–Keuls test. Data are expressed as mean ± SEM (n= 4–5 mice/group).
Fig. 5. Effects of the anandamide hydrolysis inhibitor, URB597 (1mg kg−1), on cocaine (75mg kg−1)-induced cell death theCA1 and dentate gyrus regions of themouse hippocampus 24 h
after the convulsive seizures, as revealed by ethidium homodimer staining. URB597 inhibited cocaine-induced cell death in (A) the CA1 and (B) the dentate gyrus of the hippocampus.
Representative photomicrographies of ethidium homodimer stained cells in (C–F) the CA1 and (G–J) the dentate gyrus. Dead cells were indicated by the red ﬂuorescence of ethidium
homodimer using 10× magniﬁcation. Bar size: 100 μm. **p b 0.01 and ***p b 0.001 compared to vehicle–vehicle (Veh) group; #p b 0.05 compared to Veh + cocaine group; one-way
ANOVA followed by Newman–Keuls test. Data are expressed as mean ± SEM (n = 4–6 mice/group).
Fig. 6. Effects of URB597 (1 mg kg−1) and cocaine (75 mg kg−1) on the ratio of phosphorylate by total proteins for Akt and ERK1/2. (A) URB597 increased Akt phosphorylation in
both vehicle- and cocaine-treated groups, as revealed by densitometric analysis. (B) URB597 selectively increased ERK1/2 phosphorylation in the cocaine-treated group.
(C) Representative immunoblots for phospho- (upper panel) and total-Akt expression (lower panel) in hippocampus, as revealed by densitometric analysis. (D) Representative immuno-
blots for phospho- (upper panel) and total-ERK1/2 expression (lower panel) in hippocampus. *p b 0.05 and ***p b 0.001 compared to vehicle + vehicle (Veh) group; #p b 0.05, ##p b 0.01
compared to Veh+ cocaine group; one-wayANOVA followed byNewman–Keuls test. Data are expressed asmean± SEM for percentages of basal phosphorylation (n=4–6mice/group).
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To assess the contribution of intracellular signaling events to the
action of endocannabinoids against cocaine, we determined the phos-
phorylation pattern of Akt and ERK1/2 in the hippocampus of mice
treated with either vehicle or cocaine in the presence or absence of
URB597. This FAAH inhibitor increased Akt phosphorylation in
both vehicle- and cocaine-treated mice, since there was an overall
effect of URB597 (F1,15 = 38.0, p b 0.0001); cocaine also promoted
phosphorilation (F1,15= 6.847, p= 0.0194) and no interactionwas ob-
served (F1,15 = 0.8787, ns) (Fig. 6A). Moreover, URB597 also promoted
phosphorylation of ERK1/2 in animals receiving cocaine injection.
Again, there was an overall effect of URB597 (F1,15 = 19.60, p =
0.0005), although no cocaine effect was detected (F1,15 = 1.655, ns).
There was, however, an interaction between factors (F1,15 = 4.385,
p = 0.0436). Post-hoc analysis revealed that URB597 increase phos-
phorylation in cocaine treated animals (Fig. 6B). Representative blots
are presented in Fig. 6C and D. Drug treatment did not induce changes
in total protein expression for both Akt and ERK (data not shown).
URB597protects against cocaine-induced cell death in hippocampal culture
via the CB1 receptor and PI3K
To clarify the potential mechanisms involved in URB597-mediated
effects, we added various concentrations of cocaine to primary cultured
hippocampal cells for 20 h. Adding 100 μMto 1000 μMof cocaine result-
ed in increased cell death compared to vehicle group (F6,21 = 10.95,
p b 0.0001; Fig. 7A). To assess if endogenously produced anandamide
counteracts cocaine-induced cell death, we incubated the wells with
500 μM cocaine and three concentrations of URB597. Similarly to what
we observed in the hippocampus of cocaine-treated animals, this com-
pound reduced the percentage of cell death relative to cocaine (F4,17 =Fig. 7. Effects of URB597 on cocaine-induced death in primary culturedhippocampus and the rol
inhibited cocaine-induced cell death. (C) The CB1 receptor antagonist, AM251, reversed the prot
URB597. **p b 0.01 and ***pb 0.001 compared to the respective vehicle+vehicle (Veh) groups;
♦♦p b 0.01 compared to the respective Veh + URB597 + cocaine groups; one-way ANOVA fo
experiments.6.728, p= 0.001; Fig. 7B). To conﬁrm the involvement of CB1 receptors,
we incubated the culture with AM251 (1 nM) together with URB597
(10 nM). The CB1 receptor antagonist completely reversed the neuro-
protective effect of URB597 (F3,17 = 19.13, p b 0.0001; Fig. 7C). Alto-
gether, these ﬁndings indicate that cocaine enhances the cell death in
hippocampal culture and theURB597 inhibits this effect throughCB1 ac-
tivation. Finally, considering our own observation that URB597 promot-
ed Akt phosphorylation, we hypothesized that inhibition of PI3K, which
is upstream in this signal transduction pathway, mediate the protecting
effect of CB1 receptor activation. Accordingly, the PI3K inhibitor,
LY294002 (1 μM), also reversed the protective effect of URB597
(F4,18 = 12.5, p b 0.0001, Fig. 7D). Representative stainings for this ex-
periment are presented in Fig. 8.Discussion
In the present study, we employed various approaches to test the
hypothesis that facilitation of endocannabinoid signaling protects
against cocaine neurotoxicity. We performed dose– and concentra-
tion–response experiments to select the proper doses of cocaine and
the anandamide hydrolysis inhibitor (FAAH inhibitor), URB597. Impor-
tantly, this compoundwas effective against cocaine-induced seizures in
mice. This effect possibly occurs through an increase in anandamide ac-
tion on cannabinoid CB1 receptor, since the CB1 selective agonist, ACEA,
mimicked this effect and the antagonist, AM251, prevented it. URB597
also reduced cocaine-evoked EEG activity via CB1 receptor activation.
In addition, the anticonvulsant action of URB597 was accompanied by
protection against neural activation and death in the hippocampus,
along with an increase in the phosphorylation of ERK and Akt survival
pathway. The protective effect of FAAH inhibition was conﬁrmed in
hippocampal cell culture. Finally, we demonstrated that this action ises of CB1 receptor and PI3K. (A) Cocaine increased the percentage of cell death. (B) URB597
ective effect of URB597. (D) The PI3K inhibitor, LY294002, reversed the protective effect of
#p b 0.05 and ###p b 0.001 compared to the respective Veh+cocaine groups; ♦p b 0.05 and
llowed by Newman–Keuls test. Data represent the means ± SEM of three independent
Fig. 8. Representative images for the effects of Veh+Veh+Veh, Veh+Veh+ cocaine, Veh+URB597+ cocaine, LY294002+URB597+ cocaine in primary-cultured hippocampal cells,
as revealed by ethidium homodimer-1 labeling. Upper row, calcein AM staining (green, live cells); lower row, ethidium homodimer-1 staining (red, dead cells). Bar size: 100 μm.
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mechanism.
In line with experimental and clinical observations, acute cocaine
toxicity was characterized by convulsive seizures and simultaneous
electrical spike activity in the EEG (Gasior et al., 1999; Tella et al.,
1992). Both inhibition of anandamide hydrolysis and direct activation
of the cannabinoid CB1 receptor prevented these actions. This is in
agreement with the potential antiepileptic activity of these compounds.
The effects of cannabinoid direct agonists, however, may vary across
studies, depending on the dose or model used (Blair et al., 2006;
Hofmann and Frazier, 2013; Vilela et al., 2013). In addition, they are
more prone to cause side effects, such as motor and memory impair-
ment, as compared to FAAH inhibition. Thus, the later mechanism rep-
resents a more reasonable strategy for protecting the brain against
various types of noxious stimuli (Moreira and Wotjak, 2010).
The protective effects of compounds that facilitate endocannabinoid
activity is in line with studies showing that anandamide modulate
seizures by restraining excessive excitatory neurotransmission in
certain forebrain regions, particularly the hippocampus (Marsicano
et al., 2003; Lutz, 2004; Monory et al., 2006). Both URB597 and
ACEA, however, induced bell-shaped effects upon cocaine-induced
seizures. Intriguingly, this often occurs with cannabinoid-related com-
pounds in experimental models of anxiety and epileptic seizures. Gener-
ally, intermediate doses reduce these responses via CB1 receptor
activation, whereas higher doses induce no effect (Moreira and Wotjak,
2010). Onepossible explanation for thismight be related to the activation
of the transient receptor potential vanilloid type-1 (TRPV1) channel.
Endogenous anandamide, as well as exogenous cannabinoids, activate
TRPV1 channels in the brain, generally resulting in opposite responses
as those mediated by CB1 receptor (Moreira et al, 2012). Thus, the bell-
shaped effects of URB597 and ACEA against cocaine-induced seizure
may occur due to the balanced activity upon CB1 and TRPV1 receptors.
According to this notion, these compounds would be protective at inter-
mediate doses, through CB1-mediated mechanisms (as we have shown
here), but would have no effects at higher doses, due to simultaneous ac-
tivation of CB1 and TRPV1 (Moreira and Wotjak, 2010; Moreira et al.,
2012). This possibility remains to be conﬁrmed in future experiments.
Regarding the biological bases for URB597 effects, we have focused
on the hippocampus due to its proposed role on ictal activity (Oliveira
et al., 2011; Kitchigina et al., 2013). Indeed, our data with c-Fos protein
expression, a well-established marker of neural activity (Morgan and
Curran, 1989), point to speciﬁc sub-regions of this structure as the tar-
gets for cocaine-induced ictal activity and its reversal by URB597.
Based on this result, we investigated cell death in these areas andobserved that anandamide hydrolysis inhibition reduced cocaine effects
on CA1 and dentate gyrus, in line with the on-demand protective func-
tion of endocannabinoid signaling (Fowler et al., 2010). We therefore
hypothesized that this effect occurs through activation of the PI3K/
Akt/ERK pathway, a neuroprotective mechanism coupled to CB1 recep-
tor (Ozaita et al., 2007) that promotes cell survival (Dudek et al., 1997;
Brunet et al., 2001; Zheng et al., 2002). Indeed, we observed increased
phosphorylation of Akt and ERK in the hippocampus of URB597 treated
animals. Although the effects upon ERKwere subtle, therewas amarked
increase in Akt phosphorylation. The reason for the apparent discrepan-
cymight be related to the fact that ERK is downstream to Akt in thismo-
lecular pathway.
The last series of experiments conﬁrmed these results and
established a causal relationship between the PI3K/Akt/ERK pathway
activation and the neuroprotective effect of URB597. First, we selected
a proper concentration of cocaine for in vitro studies by performing a
concentration–effect experiment. This is important considering the
large variability of cocaine concentrations across different studies
(Nassogne et al., 1995, 2004; Poon et al., 2007; Lepsch et al., 2009). In
line with previous results, we observed that cocaine promoted cell
death at a wild range of concentrations. It remains unclear, however,
to which extend these concentrations are representative of in vivo neu-
rotoxicity. Moreover, the reasons for the variability in these in vitro ef-
fects are unclear. In fact, the processes mediating its neurotoxicity
have not been clariﬁed (Wiener and Reith, 1990a,b; Planeta et al.,
2013). Some apoptotic mechanisms have been implied in this effect,
such as tumor necrosis factor TNF-α, the Bax/Bcl2 and caspase path-
ways (Dey and Snow, 2007; Dey et al., 2007), the nuclear factor NFκB
(Lepsch et al., 2009), and the gaseous messenger nitric oxide (Xu
et al., 2013).
Having established a neurotoxic concentration of cocaine for our
in vitro studies, we observed that URB597 conferred protection against
cocaine in cell culture, supporting our experiments with live animals.
This effect seems to occur via CB1 receptor activation and the PI3K intra-
cellular pathway, since it was reversed by both AM251 and LY294002.
Thus, we identiﬁed the CB1 receptor-mediated recruitment of PI3K as
a mechanism responsible for the neuroprotective effect of URB597.
This is not necessarily the only signal transduction involved in this pro-
cess. It represents, however, a logical candidate, since it is coupled to CB1
receptor and confer protection against excitotoxic stimuli (Xue et al.,
2011; Zhang and Wong, 2012).
In conclusion, employing a diversiﬁed hypothesis-drivenmethodolo-
gy, this study provides evidence that enhancing anandamide actions re-
duces the neurotoxic effects of cocaine. Themolecular processmediating
186 L.R. Vilela et al. / Toxicology and Applied Pharmacology 286 (2015) 178–187this effect involves the activation of the CB1 receptor and the PI3K intra-
cellular survival pathway in the hippocampus. Considering the limited
treatments for cocaine intoxication (Connors and Hoffman, 2013),
these mechanism may be relevant for the development of new neuro-
protective therapeutic strategies based on the endocannabinoid system.
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